
Sin spam. Cancela en cualquier momento.
Análisis de Pureza HPLC
BPC 157
CAS: 137525-51-0
Estudiado para la reparación de tendones, intestino y tejidos
BPC 157 es un péptido de investigación en la categoría de sanación / recuperación. BPC-157 es un fragmento sintético de 15 aminoácidos derivado del compuesto de protección del cuerpo gástrico humano. MiPeptidos ofrece BPC 157 en 3 tamaños con 99.4% de pureza verificada y documentación analítica completa.
- Recuperación más rápida de lesiones
- Sanación y protección intestinal
- Reducción del dolor articular
- Soporte para reparación nerviosa
Los estudios indican reducción del dolor y mejora de la movilidad en sitios de lesión dentro de los primeros 5-7 días, especialmente con inyecciones cerca del área afectada. Entre las semanas 2-4, los estudios reportan mejora funcional significativa — mejor rango de movimiento, menos rigidez y recuperación más rápida entre entrenamientos. Para problemas intestinales, los estudios frecuentemente muestran reducción de la hinchazón y mejora en la digestión dentro de las primeras 1-2 semanas. Los beneficios completos de sanación generalmente se acumulan durante el protocolo de 8 semanas, con las lesiones de tejido conectivo (tendones, ligamentos) mostrando las mejoras más dramáticas.
$13.95/vial · Everything you need to start
Sin spam. Cancela en cualquier momento.
Análisis de Pureza HPLC
Recover Faster. Heal Stronger.
The 8-week tissue repair protocol backed by 8 published studies and 4 leading physicians
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protein in human gastric juice. It is one of the most extensively studied peptides in tissue repair research, with over 100 published studies demonstrating consistent healing effects across tendons, ligaments, muscles, the GI tract, and the nervous system.
Resultados Publicados
Revisado por ParesResultados cuantificables de investigación clínica publicada.
Lo que Dicen los Expertos
4 MédicosProfesionales e investigadores líderes que han estudiado y prescrito este péptido.
Dr. William Seeds
Founder, SSRP Institute
40+ years in cellular and molecular medicine. Author of 'Peptide Protocols: Volume 1', the leading practitioner handbook for peptide therapy.
I've been amazed at how BPC-157 improves recovery in athletes. Peptides offer physicians nearly miraculous opportunities in the treatment and prevention of illness, injury, and disease.
400-600 mcg/day subcutaneous injection for tissue repair. Standard protocol: 250-500 mcg daily in the morning, 4-8 week cycles.
Fuente: Peptide Protocols: Volume 1 (ISBN: 978-0578624358)
Dr. Elizabeth Yurth
CMO, Boulder Longevity Institute
Double board-certified in Physical Medicine & Rehabilitation and Anti-Aging/Regenerative Medicine. 30+ years in sports and spine orthopedics.
BPC-157 is not only immune modulatory, it actually helps improve collagen function. Our gut makes a peptide called BPC — it's really good for the gut, unlike anti-inflammatory drugs which destroy the gut.
Subcutaneous injection preferred (once daily). Can be taken long-term. Source only from compounding pharmacies.
Fuente: Wellness Mama Podcast Ep. 674; JJ Virgin Podcast Ep. 813
Dr. Andrew Huberman
Professor of Neurobiology, Stanford University
Ph.D. in Neuroscience. Host of Huberman Lab, one of the most popular science podcasts globally.
BPC-157 encourages cell turnover and migration, assists healing through new vasculature promotion, and upregulates growth hormone. It is quite safe with low lethality.
300-500 mcg a few times per week, cycled on and off. Start with minimum effective dose. CRITICAL: Avoid if you have an existing tumor or cancer.
Fuente: Huberman Lab Podcast: Benefits & Risks of Peptide Therapeutics (April 2024)
Dr. Predrag Sikiric
Professor of Pharmacology, University of Zagreb
The world's leading BPC-157 researcher. Discovered and characterized BPC-157. 30+ years of published research, dozens of peer-reviewed papers.
Only BPC 157 regimens were consistently effective in all tested ulcer models. The beneficial effect appears to be related to strong endothelial protection.
Research doses: 10 mcg/kg to 10 pg/kg subcutaneously. Effective across a wide dose range with subcutaneous administration.
Fuente: Multiple peer-reviewed publications (University of Zagreb)
Protocolo de Dosificación
3 FasesRégimen de dosificación paso a paso compilado de profesionales líderes e investigación clínica.
Establishes tissue-level concentration during the acute healing window. Up to 600 mcg/day for severe injuries per Dr. Seeds.
Reduced dose as healing progresses. Meaningful functional gains become apparent. Rotate injection sites.
For chronic conditions or long-term remodeling. Continue subcutaneous injection at reduced frequency. Rotate injection sites.
Add 2 mL bacteriostatic water to 5 mg vial = 2,500 mcg/mL. 250 mcg = 10 units on insulin syringe; 500 mcg = 20 units.
Standard: 4-8 weeks on, 2-4 weeks off. Extended: up to 90 days continuous, then 30-day washout for receptor sensitivity.
Lyophilized: -20°C for 24+ months. Reconstituted: 2-8°C, use within 30 days. Protect from light.
Subcutaneous injection using an insulin syringe (29-31 gauge). Inject in the abdominal area or near the injury site. Rotate injection sites to avoid irritation. Subcutaneous provides superior systemic bioavailability.
Cronología de Recuperación
Basado en observaciones de investigación publicada. Los resultados individuales varían. Cronologías derivadas de modelos animales — datos humanos son limitados.
Inflammation Response & Repair Initiation
- Gene expression changes begin within 2 minutes of treatment
- Mucosal healing within 3-5 days in gastric models
- Measurable reduction in inflammatory markers within 3-7 days
- Early angiogenesis (blood vessel formation) initiates by days 4-7
- Nerve injuries show detectable axonal sprouting within 1-2 weeks
Base de investigación: Seiwerth et al. (2021) Frontiers in Pharmacology; Chang et al. (2011) J Applied Physiology
Active Structural Repair
- Tendon fibroblast migration increased up to 2.3-fold
- Growth hormone receptor expression increased up to 7-fold
- Improved tendon-to-bone junction integrity and collagen organization
- Ligament-transected animals show measurably greater tensile strength
- Muscle recovery with functional gait improvements
Base de investigación: Chang et al. (2014) Molecules; Staresinic et al. (2003) J Orthop Research
Tissue Maturation & Strengthening
- Treated tendons approach normal tissue strength by 6-8 weeks
- Enhanced bone callus formation in fracture models
- Collagen transitions from Type III to stronger Type I
- Progressive biomechanical strength gains continue
- Improved nerve electrophysiological parameters
Base de investigación: Gwyer et al. (2019) Cell Tissue Research; Vasireddi et al. (2025) HSS Journal
Long-Term Remodeling
- Tendon and ligament remodeling continues 3-6 months
- Tissue healing stabilizes; improved resilience
- Transition to maintenance dosing or cycling off
- Consider adding GHK-Cu for remodeling phase support
Base de investigación: General tissue biology; human timelines unestablished
Mecanismo de Acción
6 vías biológicas distintas a través de las cuales opera este péptido.
VEGF Upregulation & Angiogenesis
Stimulates VEGF and VEGFR2, driving new blood vessel formation to deliver nutrients and oxygen to damaged tissue.
- Upregulates VEGFR2 — more receptors means cells are more sensitive to growth signals
- Produces appropriately modulated angiogenesis in living tissue
- Critical for hypovascular tissues like tendons and ligaments
Brcic et al. (2009) PMID: 20388964
FAK-Paxillin Signaling
Activates Focal Adhesion Kinase and paxillin complexes for cell migration, adhesion, and spatial organization during healing.
- Dose-dependent phosphorylation of FAK and paxillin
- Up to 2.3-fold increase in tendon fibroblast migration
- The primary mechanism behind tendon and wound healing effects
Chang et al. (2011) PMID: 21030672
Nitric Oxide Modulation
Bidirectional NO regulator — counteracts both NO-excess and NO-deficiency states depending on physiological context.
- Activates eNOS through both VEGF-dependent and Src-caveolin pathways
- Dilates blood vessels to improve flow to injured tissue
- Supports angiogenesis, vasodilation, and vascular stability simultaneously
Seiwerth et al. (2021) PMID: 34267654
Growth Hormone Receptor Upregulation
Increases GHR expression up to 7-fold, amplifying the body's existing repair capacity rather than replacing it.
- 7-fold GHR increase by day 3 at optimal concentration
- Activates JAK2 phosphorylation for enhanced proliferation
- Dose-dependent and time-dependent effect
Chang et al. (2014) PMID: 25415472
GI Cytoprotection
Provides broad cytoprotective effects across the GI tract. Stable in gastric acid for 24+ hours — unique among peptides.
- 65.5% ulcer inhibition — outperforms famotidine
- Counteracts NSAID damage to stomach, intestine, liver, and brain
- Phase II clinical trials completed for ulcerative colitis
Xue et al. (2004) PMID: 15052688
Brain-Gut Axis Modulation
Modulates dopaminergic, serotonergic, GABAergic, and opioid systems as a brain-gut axis mediator.
- Increases dopamine and serotonin release in specific brain regions
- Counteracts amphetamine, haloperidol, and diazepam disturbances
- Maintains GI integrity while producing corresponding CNS effects
Sikiric et al. (2016) PMID: 27138887
Investigación Publicada
8 estudios revisados por pares de PubMed. Haz clic en cualquier PMID para ver el estudio completo.
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH — Journal of Applied Physiology (2011)
Hallazgo Clave: BPC-157 significantly accelerated tendon outgrowth, improved fibroblast survival under oxidative stress, and increased migration up to 2.3-fold through FAK-paxillin pathway activation.
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Staresinic M, Sebecic B, Patrlj L, et al. — Journal of Orthopaedic Research (2003)
Hallazgo Clave: Increased load at failure, Young's modulus, and Achilles Functional Index. Effective at 10 mcg/kg, 10 ng/kg, or 10 pg/kg body weight — spanning a million-fold dose range.
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
Chang CH, Tsai WC, Hsu YH, Pang JH — Molecules (2014)
Hallazgo Clave: BPC-157 increased GHR expression up to 7-fold by day 3. Growth hormone then activated JAK2 phosphorylation, enhancing cell proliferation in a dose-dependent manner.
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth S, Brcic L, Vuletic LB, et al. — Frontiers in Pharmacology (2021)
Hallazgo Clave: Gene expression changes begin at 2 minutes (7 genes). Effective across burn wounds, diabetic wounds, and excisional wounds via subcutaneous administration.
Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats
Xue XC, Wu YJ, Gao MT, et al. — World Journal of Gastroenterology (2004)
Hallazgo Clave: 65.5% ulcer inhibition — outperforming famotidine (60.8%) across all three ulcer models tested.
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P et al. — Current Neuropharmacology (2016)
Hallazgo Clave: BPC-157 modulates dopaminergic, serotonergic, GABAergic, and opioid systems. Counteracts amphetamine disturbances and diazepam tolerance.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, et al. — HSS Journal (2025)
Hallazgo Clave: Systematic review of 35 studies. 58% of patients reported improvement lasting 6+ months after intraarticular injection. Improved load-to-failure across muscle, tendon, ligament, and bone models.
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Gwyer D, Wragg NM, Wilson SL — Cell and Tissue Research (2019)
Hallazgo Clave: All studies investigating BPC 157 demonstrated consistently positive and prompt healing effects for various injury types. Particularly promising for hypovascular tissues.
Potencia tu Protocolo de Investigación
4 SinergiasLa investigación sugiere combinar BPC 157 con estos péptidos para mecanismos complementarios.

BPC-157 provides localized repair and angiogenesis while TB-500 delivers systemic anti-inflammatory and cell migration properties.
The most widely used peptide combination. Accelerates recovery across musculoskeletal injuries more comprehensively than either alone.
Comprehensive coverage from initial repair through long-term tissue reorganization. GHK-Cu activates 4,000+ genes related to tissue repair.

Combines tissue repair (BPC-157) with immune system activation (TA1) for post-surgical or immune-compromised contexts.
Optimizes both physical healing and immune function simultaneously. Ideal for recovery protocols requiring immune support.
Especificaciones
Cómo Funciona BPC 157
BPC-157 is a synthetic 15-amino acid fragment derived from human gastric body protection compound. It promotes angiogenesis by upregulating VEGF and its receptor VEGFR2, activates the FAK-paxillin pathway to enhance cell migration and wound closure, and modulates the nitric oxide system. It also interacts with the dopaminergic system and has cytoprotective effects on gastrointestinal mucosa, tendons, ligaments, and other connective tissues.
Aplicaciones de Investigación
Precios
| Tamaño | Por Vial | Paquete de 10 | Ahorro |
|---|---|---|---|
2mg | $40.00 | $340.00 | — |
5mgOferta | $49.95$50.00 | $424.57 | 0% descuento |
10mgMejor ValorOferta | $74.95$80.00 | $637.07 | 6% descuento |
Precios de paquete de 10 mostrados. Descuentos por volumen para 50+ viales — contáctenos.
Certificado de Análisis
Este COA es una muestra representativa. Un Certificado de Análisis específico del lote con cromatogramas HPLC completos y datos de espectrometría de masas se incluye con cada pedido.
Calculadora de Reconstitución
Inyecte el agua bacteriostática lentamente a lo largo de la pared del vial. Agite suavemente hasta disolver — nunca sacuda. Almacene la solución reconstituida a 2-8°C y use dentro de 30 días.
Reseñas de Clientes
Preguntas Frecuentes
Seguridad y Advertencias
Not FDA-approved for human use
Classified as a research peptide only. Banned by WADA since 2022. All information is for research and educational purposes.
Cancer risk from angiogenic properties
VEGF upregulation can theoretically increase blood flow to existing tumors. Dr. Huberman: 'Avoid BPC-157 if you have an existing tumor, or cancer, or are concerned about cancer.'
Contraindicated with active cancer or pregnancy
Complete absence of safety data in these populations. No studies have evaluated fetal, neonatal, or oncological effects.
Solo para Fines de Investigación y Educación. No es consejo médico. No para consumo humano. Consulte a un médico autorizado antes de tomar cualquier decisión relacionada con la salud.
Péptidos Relacionados
Up to 49% OffTB500
Estudiado para la reparación acelerada de tejidos y movilidad

BPC 5mg + TB 5mg
El dúo de reparación más investigado en un solo vial

BPC 10mg + TB 10mg
Péptidos de reparación de máxima concentración para investigación avanzada

GLOW (BPC 157 10mg + GHK-Cu 50mg + TB500 10mg)
Fórmula de triple péptido estudiada para el rejuvenecimiento de la piel

